|
1.
|
原著(症例報告除く)
|
Iatrogenic cerebral amyloid angiopathy: a scoping review. 2026/08
|
|
2.
|
原著(症例報告除く)
|
Impact of Cerebral Small Vessel Disease on Functional Decline: Bleeding With Antithrombotic Therapy 2 Study. 2026/07
|
|
3.
|
原著(症例報告除く)
|
Neurogenesis defects in iPSC-derived midbrain organoids of early-onset Parkinson's disease with 22q11.2 deletion syndrome. 2026/07
|
|
4.
|
原著(症例報告除く)
|
Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study. 2026/07
|
|
5.
|
原著(症例報告除く)
|
The Japanese Version of 26-Item Informant Questionnaire on Cognitive Decline in the Elderly: Development and Validation Study. 2026/07
|
|
6.
|
原著(症例報告除く)
|
Impact of Intracranial Atherosclerosis and Cerebral Small Vessel Disease on Overt Vascular Events During Antithrombotic Therapy. 2026/06
|
|
7.
|
原著(症例報告除く)
|
P2Y12 Inhibitor Response By Patient Background Factors: An Exploratory Post Hoc Subgroup Analysis of the ACUTE-PRAS Study. 2026/06
|
|
8.
|
原著(症例報告除く)
|
Association of glomerular hyperfiltration with mortality in stroke: an analysis using pooled individual patient data. 2026/05
|
|
9.
|
原著(症例報告除く)
|
Outcomes of Early Versus Later Anticoagulation in Asian Atrial Fibrillation-Related Stroke: ELAN Subgroup Analysis. 2026/05
|
|
10.
|
その他
|
【新ガイドラインに準拠した高血圧診療】臓器障害を合併する高血圧 認知症 2026/05
|
|
11.
|
原著(症例報告除く)
|
Impact of Basal Ganglia Perivascular Spaces on Ischemic and Hemorrhagic Risks in Patients Taking Antithrombotic Therapies. 2026/04
|
|
12.
|
原著(症例報告除く)
|
Lipid Management for Secondary Prevention in Atherosclerotic Cardiovascular Disease: A Scoping Review and Scientific Report. 2026/03
|
|
13.
|
原著(症例報告除く)
|
Impact of RAPID-Based Patient Selection on Endovascular Therapy Outcomes in Acute Ischemic Stroke: A Retrospective Comparative Study 2026/02
|
|
14.
|
原著(症例報告除く)
|
Long-term mortality associated with incidental unruptured intracranial aneurysms in neurologically healthy Japanese adults: the Kashima scan study. 2026/02
|
|
15.
|
原著(症例報告除く)
|
Long-term Risk of Bleeding Events in Patients Taking Antithrombotic Agents for Cerebrovascular or Cardiovascular Disease 2026/02
|
|
16.
|
原著(症例報告除く)
|
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trial. 2026/01
|
|
17.
|
その他
|
【脳血管障害 「循環器病対策推進基本法」「脳卒中と循環器病克服5ヶ年計画」を踏まえた最新の話題】脳卒中の病態・診断・診療体制に関する最新の話題 脳小血管病の病態とリスクを知る 2026/01
|
|
18.
|
原著(症例報告除く)
|
Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD). 2025/12
|
|
19.
|
原著(症例報告除く)
|
P2Y12 Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRAS. 2025/11
|
|
20.
|
原著(症例報告除く)
|
Typical distribution of hypertensive cerebral microbleed: a matched case-control study using primary aldosteronism. 2025/11
|
|
21.
|
原著(症例報告除く)
|
Zonisamide modulates cholinergic markers and alleviates levodopa-induced dyskinesia in a rat model of Parkinson's disease. 2025/11
|
|
22.
|
症例報告
|
Elderly-onset iatrogenic cerebral amyloid angiopathy presenting with lobar and deep haemorrhages. 2025/10
|
|
23.
|
原著(症例報告除く)
|
Intravenous Thrombolysis in Patients With Recent Intake of Direct Oral Anticoagulants: A Target Trial Analysis and Comparison With Reversal Agent Use. 2025/10
|
|
24.
|
原著(症例報告除く)
|
Spinocerebellar ataxia type 2 followed by amyotrophic lateral sclerosis due to a pure CAG repeat expansion in ATXN2: a case report and literature review. 2025/10
|
|
25.
|
原著(症例報告除く)
|
Prediction Model to Optimize Long-Term Antithrombotic Therapy Using Covert Vascular Brain Injury and Clinical Features. 2025/09
|
|
26.
|
原著(症例報告除く)
|
Increased risk of recurrent stroke in patients with impaired kidney function: results of a pooled analysis of individual patient data from the MICON international collaboration. 2025/08
|
|
27.
|
原著(症例報告除く)
|
Differences in P2Y12 Reaction Units Between Prasugrel and Clopidogrel by Ischemic Cerebrovascular Disease Subtypes - Subanalysis From ACUTE-PRAS. 2025/07
|
|
28.
|
原著(症例報告除く)
|
Frontotemporal Lobar degeneration with TDP-43 presenting as progressive supranuclear palsy syndrome. 2025/07
|
|
29.
|
その他
|
ARIAの発症機序と制御への展望 1型脳小血管病の病理と脳アミロイド血管症(CAA)・アミロイド関連画像異常(ARIA) 2025/05
|
|
30.
|
症例報告
|
Immunotherapy-responsive parkinsonism and anosmia in anti-NMDA receptor encephalitis with seropositive NMOSD: A case report 2025/05
|
|
31.
|
原著(症例報告除く)
|
Impact of Stroke Severity and Vascular Risk Factors on Early Versus Late Anticoagulation in Patients With Stroke and Atrial Fibrillation. 2025/05
|
|
32.
|
原著(症例報告除く)
|
Aberrant accumulation of phosphorylated BRCA1 in brainstem-type and cortical-type Lewy bodies in Lewy body disease 2025/04
|
|
33.
|
原著(症例報告除く)
|
Cerebral small vessel disease markers and long-term prognosis in spontaneous intracerebral hemorrhage: the HAGAKURE-ICH study 2025/01
|
|
34.
|
原著(症例報告除く)
|
The Kashima Scan Study 2: a protocol for a prospective observational cohort study of cerebral small vessel disease in neurologically healthy adults. 2025
|
|
35.
|
原著(症例報告除く)
|
Neuropathologic findings in a patient with hemiparkinsonism and hemiatrophy syndrome 2024/12
|
|
36.
|
総説
|
【抗血栓薬】脳出血後の抗血栓治療 2024/12
|
|
37.
|
総説
|
【実地医家における脳卒中診療のポイント】一過性脳虚血発作 2024/11
|
|
38.
|
原著(症例報告除く)
|
Sex Differences in Frequency, Severity, and Distribution of Cerebral Microbleeds 2024/10
|
|
39.
|
症例報告
|
硬膜移植が発症に関連したと考えられた若年性脳アミロイドアンギオパチーの1例 2024/10
|
|
40.
|
原著(症例報告除く)
|
Evolution of antiplatelet therapy in Japan for the management of cerebrovascular and cardiovascular disease: a survey using data from an insurance claims data information service 2024/09
|
|
41.
|
総説
|
【脳アミロイドアンギオパチー(CAA):脳血管障害と認知症のキープレイヤー】CAAによる脳血管障害所見と診断 2024/09
|
|
42.
|
原著(症例報告除く)
|
Iatrogenic cerebral amyloid angiopathy in older adults 2024/06
|
|
43.
|
総説
|
【脳卒中かもしれない!】[Chapter 6]知っておこう! 脳卒中の治療 急性期抗血栓療法はどうすれば? 2024/06
|
|
44.
|
総説
|
(II章)認知症 血管性認知症 2024/05
|
|
45.
|
総説
|
【後輩指導にも使える類似薬の使い分け早わかり!脳神経疾患の治療を理解できるくすりの本】(2章)病棟でよくみられる症状に対する治療薬 抗菌薬 2024/05
|
|
46.
|
原著(症例報告除く)
|
Cerebral small vessel disease burden for bleeding risk during antithrombotic therapy: Bleeding with Antithrombotic Therapy 2 study 2024/04
|
|
47.
|
原著(症例報告除く)
|
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds 2024/04
|
|
48.
|
総説
|
【高血圧 すぐに診療に生かしたい最新のトピックス】合併症と患者背景に応じた高血圧治療 脳血管疾患患者の血圧管理 2024/04
|
|
49.
|
その他
|
認知症診療のパラダイムシフトを迎えて(最終回) アルツハイマー型認知症とBPSD 2024/04
|
|
50.
|
原著(症例報告除く)
|
Associations for progression of cerebral small vessel disease burden in healthy adults: the Kashima scan study 2024/02
|
|
51.
|
原著(症例報告除く)
|
Clinical Associations and Prognostic Value of MRI-Visible Perivascular Spaces in Patients With Ischemic Stroke or TIA 2024/01
|
|
52.
|
総説
|
認知症診療のパラダイムシフトを迎えて アルツハイマー型認知症を含めた認知症の予防 2024/01
|
|
53.
|
原著(症例報告除く)
|
Asian flush gene variant increases mild cognitive impairment risk: a cross-sectional study of the Yoshinogari Brain MRI Checkup Cohort 2024
|
|
54.
|
原著(症例報告除く)
|
Thrombolysis for acute wake-up and unclear onset strokes with alteplase at 0.6 mg/kg in clinical practice: THAWS2 Study 2024
|
|
55.
|
原著(症例報告除く)
|
神経磁界計測装置を用いた正中神経活動電位の軸索内電流と容積電流の可視化 2024
|
|
56.
|
原著(症例報告除く)
|
Harboring Cnm-expressing Streptococcus mutans in the oral cavity relates to both deep and lobar cerebral microbleeds 2023/11
|
|
57.
|
総説
|
認知症診療のパラダイムシフトを迎えて 認知症基本法が目指すもの 2023/11
|
|
58.
|
その他
|
無症候性病変 脳小血管病update 小脳の脳微小出血分布とその解釈 2023/10
|
|
59.
|
症例報告
|
アテゾリズマブとベバシズマブ併用療法後にMRI STIR画像で翼突筋,軟口蓋,舌筋に高信号を呈した免疫チェックポイント阻害薬関連筋炎の1例 2023/09
|
|
60.
|
原著(症例報告除く)
|
Visualization of axonal and volume currents in median nerve compound action potential using magnetoneurography 2023/08
|
|
61.
|
原著(症例報告除く)
|
An autopsy case of sporadic, adult-onset amyotrophic lateral sclerosis with heterozygous p.N1935S SETX gene variant 2023/07
|
|
62.
|
症例報告
|
Imaging Findings of Subarachnoid Hemorrhaging Mimicking Limbic Encephalitis 2023/07
|
|
63.
|
原著(症例報告除く)
|
Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation 2023/07
|
|
64.
|
総説
|
神経治療のチーム医療 脳卒中チーム医療におけるメディカルスタッフの連携 2023/07
|
|
65.
|
原著(症例報告除く)
|
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation 2023/06
|
|
66.
|
原著(症例報告除く)
|
Possible association of crossed cerebellar diaschisis with cerebellar ataxia in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 2023/05
|
|
67.
|
総説
|
脳・脊髄の出血性病変 General populationでのMRI脳出血病変 2023/04
|
|
68.
|
原著(症例報告除く)
|
Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial 2023/01
|
|
69.
|
総説
|
脳小血管病 ー その負債に予防医学的閾値はあるか？ 2023/01
|
|
70.
|
原著(症例報告除く)
|
Quantitative and Morphological Assessment of Computed Tomography-depicted Gynecomastia in Spinal and Bulbar Muscular Atrophy 2022/11
|
|
71.
|
原著(症例報告除く)
|
Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trial 2022/07
|
|
72.
|
症例報告
|
Early presentation of lower urinary tract and bowel dysfunction in sporadic amyotrophic lateral sclerosis: A case report 2022/06
|
|
73.
|
その他
|
(II章)認知症 血管性認知症 2022/03
|
|
74.
|
原著(症例報告除く)
|
Increased Cerebral Small Vessel Disease Burden With Renal Dysfunction and Albuminuria in Patients Taking Antithrombotic Agents: The Bleeding With Antithrombotic Therapy 2 2022/03
|
|
75.
|
その他
|
【脳アミロイド血管症(CAA)】脳出血リスクとしてのCAA 2022/03
|
|
76.
|
その他
|
【脳梗塞-急性期治療の進歩と今後の課題】Key words 脳小血管病 2022/03
|
|
77.
|
その他
|
【発展する脳卒中診療の最前線】脳卒中病態解明の進歩 脳小血管病 その負債に予防医学的閾値はあるか? 2022/03
|
|
78.
|
原著(症例報告除く)
|
拡散強調画像上の皮質下白質高信号と皮質脳表ヘモジデリン沈着症を伴う一過性局所神経症候を繰り返した脳アミロイドアンギオパチーの1例 2021/12
|
|
79.
|
その他
|
脳アミロイド血管症は、どのように診断すればよいのか? 脳アミロイド血管症の診断には脳葉に限局する出血病変の確認が有用 2021/12
|
|
80.
|
症例報告
|
An autopsy case report of neuronal intermediate filament inclusion disease presenting with predominantly upper motor neuron features 2021/10
|
|
81.
|
総説
|
「世界の医学誌から：Incidence of Transient Ischemic Attack and Association With Long-term Risk of Stroke 一過性脳虚血発作後の長期的脳卒中発症リスク フラミンガム研究 2021/08
|
|
82.
|
総説
|
【今こそ学び直す!生理学・解剖学 あのとき学んだ知識と臨床経験をつないで、納得して動く!】(第7章)下肢 下肢の神経痛・しびれ 2021/08
|
|
83.
|
原著(症例報告除く)
|
Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis. 2021/06
|
|
84.
|
原著(症例報告除く)
|
Efficacy of pretreatment with the free radical scavenger, edaravone, for prevention of cerebral hyperperfusion after carotid artery stenting: A single-center randomized controlled trial. 2021/06
|
|
85.
|
原著(症例報告除く)
|
Histopathological analysis of retrieved thrombi from patients with acute ischemic stroke with malignant tumors 2021/05
|
|
86.
|
その他
|
脳卒中の再発予防:2020年の動向 脳微小出血と抗血栓療法 2021/05
|
|
87.
|
原著(症例報告除く)
|
Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies 2021/04
|
|
88.
|
原著(症例報告除く)
|
Influence of Microcatheter Position on First-pass Success of Thrombectomy for Acute Ischemic Stroke. 2021/02
|
|
89.
|
総説
|
各症状への対応 運動障害 2021/02
|
|
90.
|
原著(症例報告除く)
|
Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy 2021/01
|
|
91.
|
症例報告
|
特発性好酸球増加症候群による非心原性多発穿通枝梗塞の1例 2021
|
|
92.
|
原著(症例報告除く)
|
The bleeding with antithrombotic therapy study 2: Rationale, design, and baseline characteristics of the participants. 2020/12
|
|
93.
|
原著(症例報告除く)
|
Total small vessel disease score and cerebro-cardiovascular events in healthy adults: The Kashima scan study 2020/12
|
|
94.
|
総説
|
脳小血管病の臨床研究のトレンドと課題 1型脳小血管病を中心に 2020/11
|
|
95.
|
原著(症例報告除く)
|
JC virus granule cell neuronopathy associated with Ruxolitinib: A case report and review of the literature 2020/09
|
|
96.
|
原著(症例報告除く)
|
Proportion of intracerebral haemorrhage due to cerebral amyloid angiopathy in the East and West: Comparison between single hospital centres in Japan and the United Kingdom 2020/09
|
|
97.
|
総説
|
診る４ 【Expertise】 糖尿病患者における脳心血管イベントと神経画像バイオマーカー 2020/07
|
|
98.
|
原著(症例報告除く)
|
Development of an application for management of drug holidays in perioperative periods. 2020/05
|
|
99.
|
原著(症例報告除く)
|
Thrombolysis with alteplase at 0.6 mg/kg for stroke with unknown time of onset: a randomized controlled trial. 2020/05
|
|
100.
|
原著(症例報告除く)
|
Low-Dose Phosphodiesterase III Inhibitor Reduces the Vascular Amyloid Burden in Amyloid-β Protein Precursor Transgenic Mice 2020/03
|
|
101.
|
総説
|
”脳の加齢性変化”にご注意を 2020
|
|
102.
|
原著(症例報告除く)
|
看護師による簡易版National Institutes of Health Stroke Scale評価を用いた急性期脳卒中管理の妥当性の検討 2020
|
|
5件表示
|
|
全件表示(102件)
|
